MedTrace Logo

Different Medications to Induce Labor

NCT06259097 · Status: RECRUITING · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2026-03-31

No results posted yet for this study

Summary

This is a randomized controlled trial examining whether the use of misoprostol or pitocin, in combination with a foley catheter, is more effective at inducing labor in patients with a gravid BMI that is considered obese.

Conditions

  • Pregnancy
  • Labor

Interventions

DRUG

Misoprostol

25 mcg vaginally every 6 hours

DRUG

Pitocin

3-6 mL intravenously every hour

Sponsors & Collaborators

Principal Investigators

  • Nicola F Tavella, MPH · Icahn School of Medicine at Mount Sinai

  • Angela Bianco, MD · Icahn School of Medicine at Mount Sinai

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-07-02
Primary Completion
2026-06-30
Completion
2026-06-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06259097 on ClinicalTrials.gov